Biodesix, Inc. (BDSX)

Biodesix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.6	26.25	26.28	43.09	32.71	62.13
Cash & Short-Term Investments	17.6	26.25	26.28	43.09	32.71	62.13
Cash Growth	53.19%	-0.15%	-39.00%	31.72%	-47.35%	1075.29%
Receivables	7.64	8.6	7.68	5.07	3.66	15.3
Inventory	1.1	1	1.4	1.4	2.9	3.2
Restricted Cash	0.1	0.1	0.1	0.1	0.1	0.2
Other Current Assets	3.18	3.54	4.22	3.68	4.25	5.31
Total Current Assets	29.62	39.48	39.68	53.33	43.61	86.14
Property, Plant & Equipment	28.93	29.6	29.61	8.82	4.18	3.18
Goodwill	15.03	15.03	15.03	15.03	15.03	15.03
Other Intangible Assets	5.36	5.87	7.91	9.8	11.62	13.26
Long-Term Deferred Charges	-	0.7	-	-	-	-
Other Long-Term Assets	7.3	6.56	6.86	5.92	1.66	3.46
Total Assets	86.24	97.24	99.1	92.91	76.1	121.07
Accounts Payable	2.93	2.19	2.93	1.69	1.66	8.96
Accrued Expenses	7.4	9.91	7.71	8.22	7.67	7.79
Current Portion of Long-Term Debt	0.02	0.02	0.05	0.05	0.02	11.84
Current Portion of Leases	2.18	1.51	0.25	1.54	-	-
Current Unearned Revenue	0.79	0.68	0.32	0.96	1.85	3.53
Other Current Liabilities	-	-	22.15	10.38	17.76	-
Total Current Liabilities	13.32	14.32	33.42	22.84	28.96	32.13
Long-Term Debt	36.69	36.41	35.23	25	9.99	15.93
Long-Term Leases	24.97	25.44	25.16	5.25	-	-
Long-Term Unearned Revenue	0.2	0.2	0.3	0.4	0.8	1.4
Other Long-Term Liabilities	-	-	0.41	18.8	16.62	30.45
Total Liabilities	75.18	76.37	94.52	72.3	56.37	79.9
Common Stock	0.15	0.15	0.1	0.08	0.03	0.03
Additional Paid-In Capital	484.51	483.23	424.05	387.95	321.67	299.95
Retained Earnings	-473.6	-462.5	-419.57	-367.42	-301.97	-258.81
Total Common Equity	11.06	20.88	4.58	20.61	19.73	41.17
Shareholders' Equity	11.06	20.88	4.58	20.61	19.73	41.17
Total Liabilities & Equity	86.24	97.24	99.1	92.91	76.1	121.07
Total Debt	63.87	63.38	60.69	31.85	10.01	27.77
Net Cash (Debt)	-46.26	-37.14	-34.41	11.24	22.7	34.36
Net Cash Growth	-	-	-	-50.49%	-33.93%	-
Net Cash Per Share	-0.33	-0.29	-0.42	0.27	0.83	7.10
Filing Date Shares Outstanding	146.56	145.98	96.94	77.97	31.31	26.58
Total Common Shares Outstanding	146.44	145.49	96.24	77.61	30.79	26.56
Working Capital	16.31	25.17	6.27	30.5	14.65	54.02
Book Value Per Share	0.08	0.14	0.05	0.27	0.64	1.55
Tangible Book Value	-9.33	-0.03	-18.36	-4.22	-6.92	12.88
Tangible Book Value Per Share	-0.06	-0.00	-0.19	-0.05	-0.22	0.48
Machinery	8.42	8.36	8.44	7.23	7.97	7.03
Construction In Progress	0.08	0.09	-	2.95	0.02	0.38
Leasehold Improvements	28.21	28.19	24.71	2.37	2.34	1.85

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q